课题基金 / 基金详情

IU training prog. in molecular physiology and clinical mechanisms of lung disease

IU training prog. in molecular physiology and clinical mechanisms of lung disease
IU培训计划。
批准号:
7817138
负责人:
David S Wilkes
金额:
$19.17万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-04-30

项目摘要

项目成果

David S Wilkes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This T-32 Training application is anchored within the Indiana University School of Medicine, the principal School of the Indiana University Purdue University at Indianapolis (lUPUI). The proposed training program in Lung Immunobiology is provided by a multidisciplinary, highly collaborative group of established investigators and highly qualified and dedicated mentors. We have included in the training program classical elements of basic and clinical-translational, research, adding on developing novel technologies. These research skills will enable our trainees to accelerate the advancements in lung research and close the gaps in knowledge that prevented for so many decades the development of phenotypic characterization, effective preventive intervention, and disease- modifying or even curative druts for most patients with lung disease. Being led by Program Director who is a renowned physician scientist and experienced mentor who himself is a minority, and having direct support from an experienced Minority Advisory Board, this application demonstrates our commitment to the development of a successful training program for under-represented and minority scientists. The Program Director will obtain continuous advise and feedback regarding the operation of the Training Grant from several internal and one external committee, composed of leaders in academic medicine If funded, this program will provide the only research training program of pulmonary physicians and scientists in the state of Indiana, which has one of the highest incidence of chronic lung diseases in the country.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant
IL-17A and anti-col (V) humoral immunity in lung allograft rejection
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant
Administrative Core
海外基金